3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
8
Other
2
NET
2
Endocrine
2
CNS
2
Thoracic
1
Sarcoma
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Brain Neoplasms
593
Glioblastoma
573
Glioma
298
Central Nervous System Neoplasms
208
Gliosarcoma
177
Neuroblastoma
175
Astrocytoma
174
Oligodendroglioma
112
Carcinoma, Non-Small-Cell Lung
92
Medulloblastoma
80
Breast Neoplasms
74
Ependymoma
61
Sarcoma
60
Meningioma
60
Neoplasm Metastasis
57
Recurrence
56
Melanoma
56
Neoplasms
51
Lung Neoplasms
48
Neurofibromatosis 1
43
Meningeal Carcinomatosis
40
Osteosarcoma
39
Pheochromocytoma
38
Rhabdomyosarcoma
37
Wilms Tumor
36
Paraganglioma
35
Lymphoma, Non-Hodgkin
32
Neuroectodermal Tumors, Primitive, Peripheral
29
Lymphoma
27
Sarcoma, Ewing
26
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Intestinal Diseases
×
CNS
×
Clear all
NCT04755920
2024-05-09
SGM-CBM
Leiden University Medical Center
Phase 2
Unknown
10 enrolled
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts